Archiv
Archiv
We regularly offer webinars and events on current topics. Our experts inform you about relevant developments in the areas of audit, tax and law, as well as accounting and sustainability.
Want to know more?
Mazars live at EXPO REAL, October 4 - 6, 2022 in Munich, Germany
Global change is also affecting the real estate industry. Social megatrends such as sustainability, changing consumer behaviour, and increasing digitisation pose major challenges for the industry. At EXPO REAL 2022, our experts will provide useful insights that will optimally prepare you for the future.
Nachhaltigkeit für das selbst geschaffene Vermögen – das Wichtigste für sich selbst regeln
20. Oktober 2022 | 17:30 – 21:30 Uhr
In dieser Vortragsveranstaltung von Mazars und der PSD Bank erfahren Sie, wie Sie Ihre privaten Vermögenswerte nachhaltig auf die nächste Generation übertragen.
In dieser Vortragsveranstaltung von Mazars und der PSD Bank erfahren Sie, wie Sie Ihre privaten Vermögenswerte nachhaltig auf die nächste Generation übertragen.
Side event of the MEDICA: "Go-to-Market Accelerator - legal and commercial aspects for digital health products in Germany"
17 November 2022 | 10:00 am to 7:00 pm
The development of new smart technologies in the field of medical devices is progressing rapidly and introducing these in the German market involves numerous legal and economic considerations: What are the marketing opportunities for digital health products in the German healthcare market? How does the German healthcare system compare internationally? And what civil and criminal law consequences do companies face if they violate compliance regulations?
The development of new smart technologies in the field of medical devices is progressing rapidly and introducing these in the German market involves numerous legal and economic considerations: What are the marketing opportunities for digital health products in the German healthcare market? How does the German healthcare system compare internationally? And what civil and criminal law consequences do companies face if they violate compliance regulations?